Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingjuan Huang

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|October 17, 2021
The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?Jiayao Ma, Lingjuan Huang, Die Hu, et al.
Alternative Therapies in Health and Medicine|October 26, 2023
The Application Value of CICARE Communication Mode Combined with Detailed Nursing on the Related Factors of Poor Prognosis of Patients After Gastric Cancer ResectionShuiqin Xu, Lingjuan Huang, Haiyan Xing, et al.
Discover Oncology|June 3, 2026
A bibliometric analysis of the research landscape of lenalidomide resistance in multiple myelomaRuihua Li, Lingjuan Huang, Zhuanghui Hao, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Lysosomal reduced thiols are essential for mouse embryonic developmentCharles H Adelmann, Avanthika Venkatachalam, Lingjuan Huang, et al.
Journal of Oncology|October 20, 2022
Combination of Tumor Mutational Burden and DNA Damage Repair Gene Mutations with Stromal/Immune Scores Improved Prognosis Stratification in Patients with Lung AdenocarcinomaDongping Wu, Lingjuan Huang, Jiwei Mao, et al.
Frontiers in Cellular and Infection Microbiology|June 23, 2025
Evolution of ceftazidime-avibactam resistance driven by variation in <i>bla</i> <sub>KPC-2</sub> to <i>bla</i> <sub>KPC-190</sub> during treatment of ST11-K64 hypervirulent <i>Klebsiella pneumoniae</i>Zeshi Liu, Jing Lei, Xue Zhang, et al.
Hematology (Amsterdam, Netherlands)|March 21, 2019
Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimensJu Bai, Jianli Wang, Yun Yang, et al.
Life Sciences|February 21, 2018
Focusing on long non-coding RNA dysregulation in newly diagnosed multiple myelomaYing Shen, Yuandong Feng, Hongli Chen, et al.
Molecular Carcinogenesis|March 13, 2024
BATF promotes extramedullary infiltration through TGF-β1/Smad/MMPs axis in acute myeloid leukemiaRu Zhang, Jiyu Miao, Meng Zhai, et al.
Theranostics|November 28, 2022
Signatures of EMT, immunosuppression, and inflammation in primary and recurrent human cutaneous squamous cell carcinoma at single-cell resolutionXin Li, Shuang Zhao, Xiaohui Bian, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Experimental & Clinical Cancer Research : CR|October 17, 2021
The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?Jiayao Ma, Lingjuan Huang, Die Hu, et al.
Alternative Therapies in Health and Medicine|October 26, 2023
The Application Value of CICARE Communication Mode Combined with Detailed Nursing on the Related Factors of Poor Prognosis of Patients After Gastric Cancer ResectionShuiqin Xu, Lingjuan Huang, Haiyan Xing, et al.
Discover Oncology|June 3, 2026
A bibliometric analysis of the research landscape of lenalidomide resistance in multiple myelomaRuihua Li, Lingjuan Huang, Zhuanghui Hao, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Lysosomal reduced thiols are essential for mouse embryonic developmentCharles H Adelmann, Avanthika Venkatachalam, Lingjuan Huang, et al.
Journal of Oncology|October 20, 2022
Combination of Tumor Mutational Burden and DNA Damage Repair Gene Mutations with Stromal/Immune Scores Improved Prognosis Stratification in Patients with Lung AdenocarcinomaDongping Wu, Lingjuan Huang, Jiwei Mao, et al.
Frontiers in Cellular and Infection Microbiology|June 23, 2025
Evolution of ceftazidime-avibactam resistance driven by variation in <i>bla</i> <sub>KPC-2</sub> to <i>bla</i> <sub>KPC-190</sub> during treatment of ST11-K64 hypervirulent <i>Klebsiella pneumoniae</i>Zeshi Liu, Jing Lei, Xue Zhang, et al.
Hematology (Amsterdam, Netherlands)|March 21, 2019
Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimensJu Bai, Jianli Wang, Yun Yang, et al.
Life Sciences|February 21, 2018
Focusing on long non-coding RNA dysregulation in newly diagnosed multiple myelomaYing Shen, Yuandong Feng, Hongli Chen, et al.
Molecular Carcinogenesis|March 13, 2024
BATF promotes extramedullary infiltration through TGF-β1/Smad/MMPs axis in acute myeloid leukemiaRu Zhang, Jiyu Miao, Meng Zhai, et al.
Theranostics|November 28, 2022
Signatures of EMT, immunosuppression, and inflammation in primary and recurrent human cutaneous squamous cell carcinoma at single-cell resolutionXin Li, Shuang Zhao, Xiaohui Bian, et al.
Pageof 2